For many technology-driven companies, the pressure to monetize patent portfolios has never been higher. Boards and executive teams increasingly expect intellectual property to move beyond defensive positioning and start contributing tangible revenue.
Yet in some of the most valuable industries—semiconductors, advanced manufacturing, photonics, and industrial processes—the classic licensing playbook breaks down.
Why? Because Evidence of Use (EOU) often doesn’t exist in any visible or provable form.
The Hidden Divide Between B2C and B2B Infringement
In B2C markets, infringement identification is informed by repeated, real-world enforcement experience and transparent market dynamics. If a patented feature is implemented in a consumer-facing product, proof is often publicly available:
- Product manuals
- Marketing material
- Online demos and videos
- Independent reviews
If a smartphone unlocks using facial recognition, the feature is observable. Mapping a patent claim to a product function is feasible, and infringement analysis follows a clear, defensible path.
B2B environments are fundamentally different.
In sectors such as semiconductor manufacturing, LED fabrication, or advanced materials, patents often protect processes rather than visible end features. The value sits in how something is made—not what the end user sees.
A semiconductor chip may enable Bluetooth connectivity or facial recognition. Still, the manufacturing steps behind that chip—lithography methods, deposition processes, etching techniques—are executed deep inside foundries and labs, deliberately shielded from public view.
This fact creates a structural problem for licensing teams.
Why Classic Evidence of Use Fails in Manufacturing-Led Industries
In B2B manufacturing contexts:
- The final product reveals almost nothing about the underlying process.
- Public documentation stops at high-level functionality.
- Manufacturing methods are treated as trade secrets.
- On-site inspections are impossible.
Even if a patent owner strongly suspects infringement, there is no product brochure, teardown video, or user manual that proves it.
Companies like semiconductor foundries may all arrive at similar outcomes—more minor chips, higher efficiency, better yields—but the exact steps used to achieve those outcomes are invisible to outsiders.
As a result, many patent owners assume monetization is impossible and leave high-value process patents dormant.
That assumption is wrong.
From “No Evidence” to “Actionable Indications”
When direct EOU cannot be established, the question shifts from proof to probability.
Instead of asking, “Can we prove infringement?” the more strategic question becomes:
“Can we build a defensible indication that a competitor is likely using our patented process?”
This point is where supplementary intelligence changes the licensing equation.
Rather than relying on product documentation, a structured approach looks at indirect but highly telling signals, including:
- The target company’s own patent filings
- R&D focus areas revealed through prosecution trends
- Published research papers and technical disclosures
- Conference presentations and technical talks
- Technology roadmaps inferred from hiring, partnerships, and investments.
None of these sources, individually, proves infringement. Collectively, they often tell a compelling story.
If a competitor consistently files patents that align with specific manufacturing steps, or publicly discusses process optimizations that mirror patented methods, the gap between suspicion and strategic leverage narrows significantly.
Licensing Without Evidence of Use: What Actually Happens
It is essential to be clear: most licensing outcomes do not start in court.
In reality, the majority of licensing deals – especially in B2B technology sectors – begin with informed commercial conversations, not litigation.
Armed with well-structured supplementary analysis, a patent owner can:
- Approach a target company with credible, non-accusatory positioning.
- Demonstrate alignment between patented processes and the target’s disclosed R&D direction.
- Open discussions around licensing, collaboration, or cross-licensing
- Strengthen negotiation leverage without claiming definitive infringement.
The message is rarely “we have proof you are infringing.”
Instead, it is closer to:
“Based on your published research and patent activity, there are strong indications that our patented processes align with your manufacturing approach. We believe there is an opportunity to discuss licensing or collaboration.”
This shift—from accusation to informed engagement—is what makes B2B licensing viable even in the absence of classic EOU.
Why This Matters Now
The urgency behind this approach is not theoretical.
Across industries, executive leadership is pushing IP teams to:
- Generate revenue from existing patent portfolios.
- Justify long-term R&D investments.
- Reduce the number of “idle” patents on balance sheets.
In domains where direct evidence of use will never be publicly available, supplementary intelligence becomes the only realistic path to monetization.
Without it, valuable process patents remain untapped—not because they lack value, but because companies lack the methodology to act on that value.
Turning Invisible Processes into Strategic Assets
B2B patent licensing requires a different mindset. It demands comfort with uncertainty, sophistication in indirect analysis, and the ability to translate technical signals into commercial strategy.
When done well, this approach does more than unlock licensing revenue. It enables:
- Earlier market engagement
- Stronger negotiation positions
- Long-term cross-licensing relationships
- A clearer understanding of competitive R&D direction
In industries where innovation happens behind closed doors, the absence of evidence does not mean there is no opportunity. It simply requires a more intelligent way of seeking it out.
